BRISTOL-MYERS SQUIBB COMPANY
Patent Owner
Back to search results Back to News FeedStats
- 10 2,030 US PATENTS IN FORCE
- 89 US APPLICATIONS PENDING
- Feb 01, 2018 most recent publication
Details
- 2,030 Issued Patents
- 325 Issued in last 3 years
- 87 Published in last 3 years
- 36,888 Total Citation Count
- Jun 27, 1975 Earliest Filing
- 1,660 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
MATTERS
Rank in Class
Intl Class
Technology
MATTERS
Rank in Class
- No Technologies to Display
Top Patents (by citation)
Upgrade to the Premium Level to View Top Patents for this Owner. Learn More |
Patent #
Title
Filing Date
Issue Date
Intl Class
CITATIONS
5508272
Compounds containing a fused bicycle ring and processes therefor
May 05, 94
Apr 16, 96
[C07D, A61K]
131
5760246
Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
Dec 17, 96
Jun 02, 98
[C07D]
114
5595872
Nucleic acids encoding microsomal trigyceride transfer protein
Sep 03, 93
Jan 21, 97
[C12N, C07H, C12Q]
110
5770197
Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules
Jan 22, 93
Jun 23, 98
[A61K, C07K]
105
- No Patents to Display
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0030,057
SUBSTITUTED IMIDAZO[1,5-a]PYRAZINES AS CGRP RECEPTOR ANTAGONISTS
Sep 21, 17
Feb 01, 18
[C07D]
2018/0002,432
ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF
Jul 11, 17
Jan 04, 18
[A61K, G01N, C07K]
2017/0368,172
USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH ANTI-CD27 ANTIBODY IN CANCER TREATMENT
Jun 03, 17
Dec 28, 17
[A61K, C07K]
2017/0360,759
CARBAMOYLOXYMETHYL TRIAZOLE CYCLOHEXYL ACIDS AS LPA ANTAGONISTS
Jun 20, 17
Dec 21, 17
[C07D, C07C, A61K]
2017/0362,259
PROCESS AND INTERMEDIATES FOR MAKING TUBULYSIN ANALOGS
Jun 15, 17
Dec 21, 17
[C07F, C07D]
2017/0354,718
FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN
Apr 19, 17
Dec 14, 17
[A61K]
2017/0326,247
ANTIBODY-DRUG CONJUGATES OF TUBULYSIN ANALOGS WITH ENHANCED STABILITY
May 05, 17
Nov 16, 17
[A61K, C07K]
2017/0326,249
ANTIBODY-DRUG CONJUGATE OF AN ANTI-GLYPICAN-3 ANTIBODY AND A TUBULYSIN ANALOG, PREPARATION AND USES
May 05, 17
Nov 16, 17
[A61K, C07K]
- No Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9879046
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
Jul 07, 16
Jan 30, 18
[G01N, A61K, C07K]
9868743
Macrocyclic molecules as HCV entry inhibitors
Feb 04, 14
Jan 16, 18
[A01N, C07D, A61P, A61K]
9862715
Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors
Dec 07, 15
Jan 09, 18
[C07D]
9862730
Imidazothiadiazole derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
Apr 24, 13
Jan 09, 18
[C07D, A61K]
9862758
Inhibitors of type 2 vascular endothelial growth factor receptors
Mar 15, 16
Jan 09, 18
[C12N, C07H, A61K, C07K]
- No Patents to Display
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0260,232
TUBULYSIN COMPOUNDS, METHODS OF MAKING AND USE
ABAN
May 23, 17
Sep 14, 17
[A61K, C07K]
2017/0057,961
MACROCYCLIC FACTOR XIA INHIBITORS CONDENSED WITH HETEROCYCLES
ABAN
Jan 30, 15
Mar 02, 17
[C07D]
2016/0318,904
SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS AS FACTOR XIA INHIBITORS
ABAN
Jul 08, 16
Nov 03, 16
[C07D]
2016/0304,607
COMPOSITIONS COMPRISING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTIBODY
ABAN
Apr 15, 16
Oct 20, 16
[C07K]
2016/0274,108
DIAGNOSTIC METHODS FOR PAR4 ANTAGONIST THERAPY
ABAN
Oct 24, 14
Sep 22, 16
[A61K, G01N]
2016/0152,686
FIBRONECTIN BASED SCAFFOLD DOMAINS LINKED TO SERUM ALBUMIN OR MOIETY BINDING THERETO
ABAN
Mar 12, 14
Jun 02, 16
[C07K]
2016/0153,990
METHODS FOR IDENTIFYING PATIENTS AT RISK FOR COSTIMULATION BLOCKADE RESISTANT REJECTION
ABAN
Mar 27, 14
Jun 02, 16
[G01N]
2016/0038,502
HIV TREATMENT FORMULATION OF ATAZANAVIR AND COBICISTAT
ABAN
Oct 06, 14
Feb 11, 16
[A61K]
2015/0336,975
COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION
ABAN
Aug 03, 15
Nov 26, 15
[C07D]
2015/0299,804
BIOMARKERS FOR PREDICTING CLINICAL RESPONSE OF CANCER PATIENTS TO TREATMENT WITH IMMUNOTHERAPEUTIC AGENT
ABAN
Nov 14, 13
Oct 22, 15
[C12Q, G06F, C07K]
2015/0290,316
COMBINATION OF ANTI-KIR ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT CANCER
ABAN
Oct 02, 13
Oct 15, 15
[A61K, C07K]
2015/0252,097
TARGETED THERAPEUTICS BASED ON ENGINEERED PROTEINS FOR TYROSINE KINASES RECEPTORS, INCLUDING IGF-IR
ABAN
Mar 16, 15
Sep 10, 15
[A61K, C07K]
2015/0225,790
METHODS FOR IDENTIFYING SUBJECTS WITH AN INCREASED LIKELIHOOD OF RESPONDING TO CCR1 ANTAGONIST
ABAN
Apr 18, 13
Aug 13, 15
[C12Q]
2015/0210,691
LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS
ABAN
Apr 08, 15
Jul 30, 15
[C07D, A61K, A61J, B65D]
- No Patents to Display
Top Inventors for This Owner
Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More |
Inventor Name
Address
MATTERS
- No Inventor to Display
Free |
Premium |
Professional |
Enterprise |
Patent Searching | ![]() |
![]() |
![]() |
![]() |
|||
Technology Searching | ![]() |
![]() |
![]() |
![]() |
|||
Owner and Inventor Searching | ![]() |
![]() |
![]() |
![]() |
|||
Patent Analytics | ![]() |
![]() |
![]() |
![]() |
|||
Owner Analytics | ![]() |
![]() |
![]() |
![]() |
|||
Attorney Analytics | ![]() |
![]() |
![]() |
![]() |
|||
Inventor Analytics | ![]() |
![]() |
![]() |
![]() |
|||
Technology Analytics | ![]() |
![]() |
![]() |
![]() |
|||
Mobile Searching | ![]() |
![]() |
![]() |
![]() |
|||
Tagging | ![]() |
![]() |
![]() |
||||
Advanced Patent Analytics | ![]() |
![]() |
![]() |
||||
Advanced Owner Analytics | ![]() |
![]() |
![]() |
||||
Mobile Portfolio/Analytics | ![]() |
![]() |
![]() |
||||
Detailed Attorney Information | ![]() |
![]() |
|||||
Prosecution analytics | ![]() |
![]() |
|||||
Pre-publication Data | ![]() |
![]() |
|||||
Monthly PAIR Information and Watches | ![]() |
![]() |
|||||
Number of patents in all portfolios | 100 (maximum) | 1000 (maximum) | 2000 (maximum) | Unlimited | |||
Watches in all categories (Watch) | 20 (maximum) | 10 (maximum) | 50 (maximum) | 500 (maximum) | Unlimited | ||
Maximum number of portfolios | 5 (maximum) | 10 (maximum) | 100 (maximum) | Unlimited | |||
Maximum number of comparisons | 1 (maximum) | 5 (maximum) | 20 (maximum) | Unlimited |
FREE |
$9.95/mo |
$39.95/mo |
$99.95/mo |
||||
PAIR Watch Weekly Update | $2.75/mo/patent | $2.65/mo/patent | |||||
PAIR Watch Daily Update | $5.75/mo/patent | $5.65/mo/patent | |||||
Trial Version | Trial Version | Trial Version | |||||
Current Plan Upgrade Now | Current Plan Upgrade Now | Current Plan Upgrade Now | Current Plan Upgrade Now |
We are sorry but your current membership does not allow you access to this feature. Upgrade to our Premium Level to View Top Owners in Class/Subclass! Learn More |